bioRxiv · 10.1101/572958
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Abstract
Recently it has become possible to query the great diversity of natural antibody repertoires using Next Generation Sequencing (NGS). These methods are capable of producing millions of sequences in a single experiment. Here we compare Clinical Stage Therapeutic antibodies to the [~]1b sequences from 60 independent sequencing studies in the Observed Antibody Space Database. Of the 242 post Phase I antibodies, we find 16 with sequence identity matches of 95% or better for both heavy and light chains. There are also 54 perfect matches to therapeutic CDR-H3 regions in the NGS outputs, suggesting a nontrivial amount of convergence between naturally observed sequences and those developed artificially. This has potential implications for both the discovery of antibody therapeutics and the legal protection of commercial antibodies.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Krawczyk, K., Kovaltsuk, A., Raybould, M., Deane, C. M.. 2019-03-09. Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories. https://doi.org/10.1101/572958
Cite the original work for its findings. Save a collection to share your selection of sources.